USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: ANALIZA, INC.
Address: ANALIZA, INC.
408 GLEN PARK DR
BAY VILLAGE, OH 44140
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (440) 808-8708

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $580,337.00 8
SBIR Phase II $1,826,678.00 4

Award List:

DEVELOPMENT OF A HUMANE TATTOO SYSTEM FOR VISUAL AND INSTRUMENTAL PERMANENT IDENTIFICATION OF SMALL RODENTS.

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

DEVELOPMENT OF A HUMANE TATTOO SYSTEM FOR VISUAL AND INSTRUMENTAL PERMANENT IDENTIFICATION OF SMALL RODENTS.

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $349,688.00
Abstract:
This phase 1 project will result in development of pigments, tattoo equipment and procedures for visual and instrumental identification of dark colored rodents. the b6c3f1 brown mouse will be used as a model. various black and colored pigments will be evaluated along with light sources for visual… More

DEVELOPMENT OF HUMANE TATTOO SYSTEM OF SMALL RODENTS

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $16,252.00

DEVELOPMENT OF HUMANE TATTOO SYSTEM OF SMALL RODENTS

Award Year / Program / Phase: 1991 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $349,688.00
Abstract:
The phase i project resulted in the development of several tattoo pigments that were effective in identifying b6c3f1 brown mice in a 3-month study. these pigments did not affect growth or mortality; however, one pigment was cytotoxic to in vitro mouse lymphoma cells. the phase ii project will… More

NEW METHOD FOR MEASUREMENT OF CDT LEVEL IN SERUM

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Zaslavsky, boris y
Award Amount: $99,750.00
Abstract:
DESCRIPTION: (Adapted from the applicant's abstract) The innovation described in this proposal is aimed at providing a new method for detection of carbohydrate-deficient transferrin (CDT) in human blood as a biochemical marker of alcohol abuse. CTD has been extensively shown to be a sensitive and… More

MICROHETEROGENEITY IN BIOPRODUCTS

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Zaslavsky, boris y
Award Amount: $99,938.00
Abstract:
The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemical structure for both traditional drugs and biopharmaceuticals.… More

NEW METHOD FOR QSAR FOR BIOPHARMACEUTICAL PRODUCTS

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Zaslavsky, boris y
Award Amount: $94,588.00

MICROHETEROGENEITY IN BIOPRODUCTS

Award Year / Program / Phase: 1998 / SBIR / Phase II
Agency: HHS
Principal Investigator: Zaslavsky, boris y
Award Amount: $749,995.00
Abstract:
The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemical structure for both traditional drugs and biopharmaceuticals.… More

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Boris Y. Zaslavsky
Award Amount: $0.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase II
Agency: HHS
Principal Investigator: Boris Y. Zaslavsky
Award Amount: $377,307.00

RAPID QUALITY CONTROL TECHNOLOGY FOR BIODEFENSE VACCINES

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Y. B. Zaslavsky
Award Amount: $99,242.00
Abstract:
DESCRIPTION (Provided by applicant): Due to the anticipated significant increase in the number of potential vaccines for CDC Category A agents in the near future, it is imperative that a rapid response quality control technology be developed and validated. The key objective of this proposal is to… More

Structural Signatures for Quality Control of Proteins

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Boris Y. Zaslavsky
Award Amount: $120,567.00
Abstract:
DESCRIPTION (provided by applicant): Higher-order structural information for biomolecules is an important component of quality control activities for recombinant proteins. Unfortunately, detailed structural information typically require highly complex, time-consuming experimental techniques (e.g.,… More